We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 21, 2021

Apixaban and Dalteparin for Treatment of VTE in Patients With Different Sites of Cancer

Thrombosis and haemostasis

 

Additional Info

Thrombosis and haemostasis
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer
Thromb. Haemost. 2021 Sep 16;[EPub Ahead of Print], G Agnelli, A Muñoz, L Franco, I Mahé, B Brenner, JM Connors, G Gussoni, EN Hamulyak, C Lambert, MR Suero, R Bauersachs, A Torbicki, C Becattini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.